CD4 and cancer: Conventional DC type 1 and 2 (cDC1 and cDC2) prime CD8+ and CD4+ T cell subsets, respectively, toward viral infections and cancer via antigen-loaded major histocompatibility complexes (MHC) to activate T cell responses towards the corresponding antigen of interest (30, 31).